← Leaderboards
Joan A Conry
Children'S Research Institute
$152,322
Attributed
$152,322
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $71.9K · FY2006–09$100K$75K$50K$25K$0
'06
'07
'08
'09
Funding mix
By agency
NIH$152,322 · 7
By mechanism
M01$152,322 · 7
Top collaborators
No co-investigators on record.
Most similar at Children'S Research Institute
Same institution · by research overlap
- Madison Mehalani Berl$1,982,436
- Andrea Lynne Gropman$6,318,642
- Roger Packer$5,643,404
- Christopher Ryan Heier$3,542,686
- Leigh Sepeta$912,200
Others in their field
Top investigators on “United States National Institutes Of Health”
- Leonard Freedman · Leidos Biomedical Research, Inc.$816,847,401
- Sonia M Thomas · Research Triangle Institute$701,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$642,073,624
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$513,687,120
- Tracy L Nolen · Research Triangle Institute$474,487,152
Research focus
United States National Institutes Of HealthComputer Retrieval Of Information On Scientific Projects DatabaseFundingGrantInstitutionResearch PersonnelResourcesSourceDrug KineticsAbsence EpilepsyPharmacodynamicsPharmacogeneticsChildhoodEpilepsyRandomizedDropsDoseSeizuresGastaut SyndromeClobazamSafetyClinical Research
Grant awards (7)
CHILDHOOD ABSENCE EPILEPSY: RX, PK-PD PHARMACOGENETICS$36,748
M01 · FY2009 · RR · contact PI
OV-1002: SAFETY AND EFFICACY OF CLOBAZAM IN SUBJECTS WITH LENNOX-GASTAUT SYN$36,282
M01 · FY2008 · RR · contact PI
CHILDHOOD ABSENCE EPILEPSY: RX, PK-PD PHARMACOGENETICS$35,596
M01 · FY2008 · RR · contact PI
OV-1002: SAFETY AND EFFICACY OF CLOBAZAM IN SUBJECTS WITH LENNOX-GASTAUT SYN$16,845
M01 · FY2007 · RR · contact PI
CHILDHOOD ABSENCE EPILEPSY: RX, PK-PD PHARMACOGENETICS$16,526
M01 · FY2007 · RR · contact PI
CHILDHOOD ABSENCE EPILEPSY: RX, PK-PD PHARMACOGENETICS$9,809
M01 · FY2006 · RR · contact PI
OV-1002: SAFETY AND EFFICACY OF CLOBAZAM IN SUBJECTS WITH LENNOX-GASTAUT SYN$516
M01 · FY2006 · RR · contact PI